Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $99 million versus the consensus estimate of $97.21 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.